A previous investigation showed that hyperoside has anticancer activity against lung cancer cells by upregulating FoxO1 via CCAT1 [55]; additionally, it showed an inhibitory effect against SW620 human colorectal cancer cells via the induction of the p.53 signaling pathway and apoptosis [56]. This evidence concerns the gene TP53 and lung cancer.